This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Mylan Inc (MYL)

NASDAQ: Health Care

Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 6.91B 6.80B 6.13B 5.45B
Cost of Sales 3.35B 3.34B 3.06B 2.81B
Gross Operating Profit 3.56B 3.45B 3.07B 2.64B
Selling, General, and Administrative Expenses 1.41B 1.40B 1.21B 1.09B
Research & Development 507.82M 401.34M 294.73M 282.15M
Operating Income before D & A (EBITDA) 1.64B 1.65B 1.56B 1.27B
Depreciation & Amortization 516.00M 546.60M 510.69M 422.79M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -74.85M 6.56M -14.87M -34.18M
Special Income / Charges 14.64M 0.00 -48.56M -127.06M
Total Income Before Interest Expenses (EBIT) 1.06B 1.11B 990.58M 687.41M
Interest Expense 313.34M 308.70M 335.94M 331.46M
Pre-Tax Income 747.34M 804.08M 654.64M 355.94M
Income Taxes 120.81M 161.14M 115.83M 10.40M
Minority Interest 2.82M 2.08M 1.99M 427.00K
Net Income From Continuing Operations 626.53M 642.93M 538.80M 345.54M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 626.53M 642.93M 538.80M 345.54M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 623.71M 640.85M 536.81M 345.12M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
611.89M 642.93M 587.36M 472.60M
Preferred Dividends
Net Income Available To Common 626.53M 642.93M 538.80M 224.01M
Basic EPS from Continuing Ops. 1.63 1.54 1.25 0.69
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.63 1.54 1.25 0.69
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.63 1.54 1.25 0.69
Basic Normalized Net Income/Share 1.59 1.54 1.36 0.94
EPS fr Continuing Ops. 1.58 1.52 1.22 0.68
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.58 1.52 1.22 0.68
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.58 1.52 1.22 0.68
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.54 1.52 1.33 0.93
Dividends Paid per Share 0.00 0.00 0.00 0.00
MYL News

Analysts Ratings for MYL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 9 9 9 9
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET MYL ANALYST REPORT

Brokerage Partners

MYL Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs